Regulatory

Inside the FDA’s Real-Time Clinical Trial Experiment

The FDA is monitoring live clinical trial data using AI in a landmark pilot with AstraZeneca and Amgen. What real-time oversight could mean...

Read More
The Investigator's Brochure Has Become a Regulated Safety Instrument. Is Your Organisation Ready?

ICH E6 R3 has reset expectations for the Investigator's Brochure. What sponsors and medical writers need to know about safety reporting in...

Read More
A New Era for UK Clinical Trials? Analysing the April 2026 Regulatory Overhaul

The UK's biggest clinical trials reform in 20 years takes effect April 2026. What the new MHRA regulations mean for sponsors and trial...

Read More
FDA’s Plausible Mechanism Framework for Ultra-Rare Disease Therapies

How the FDA’s Plausible Mechanism Framework could transform personalised genomic therapies and treatment development for ultra-rare...

Read More
AI: Solving a Problem That Doesn’t Exist

When trial findings are not reported the resulting gaps in the scientific record distort evidence synthesis, misdirect clinical...

Read More
The Enduring Problem of Under-Reporting

When trial findings are not reported the resulting gaps in the scientific record distort evidence synthesis, misdirect clinical...

Read More
The Growing Role of Patient-Reported Outcomes in Clinical Study Reports

The world's first human COVID challenge trial has been given the green light

Read More
Increasing Complexity of Clinical Study Reports

The world's first human COVID challenge trial has been given the green light

Read More
The European Biotech Act: Implications for Early Clinical Pharmacology and Phase 1 Industry in Europe and the UK

Discover how artificial intelligence is affecting medical writing, where its limits lie, and why human judgement remains critical for...

Read More
Paracelsus and the Origins of Modern Science

How Paracelsus helped shape modern scientific thinking through observation, toxicology, and early chemical medicine.

Read More
From a Living Hell to a Licensed Therapy: Niche's Role in the Approval of Waskyra

The EMA has approved Waskyra for Wiskott Aldrich Syndrome. A personal reflection on Niche's decade long role in this gene therapy's...

Read More
A Guide to Pre-writing Strategies for Optimal Outcomes

Struggling with scientific writing? Discover evidence-based strategies to beat procrastination, structure your work and write with more...

Read More
Why Stability Testing Can Make or Break Your Clinical Trial Application

Stability data is a common source of regulatory deficiencies in clinical trial applications. A practical guide to ICH requirements and shelf...

Read More
Phase 1’s future in the UK

Phase I is the lifeblood or new medicines. The UK’s Phase I representative body,

Read More
Metathesiophobia: from preclinical to clinical development

Having worked in early-stage clinical pharmacology for over 30 years

Read More
Mandatory adoption of the European Clinical Trials System approaches

Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the deadline for...

Read More
iOnctura's Innovation Passport

The clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer,

Read More
Impact of the COVID-19 pandemic on clinical trial conduct

Early in 2020, COVID-19 was spreading rapidly across the globe.

Read More
Rational Vaccines wins MHRA ILAP passport

Rational Vaccines (RVx) announces MHRA Innovation Licensing and Access Pathway (ILAP) approval for their live attenuated vaccine candidate...

Read More
Challenge trials: What you need to know

The world's first human COVID challenge trial has been given the green light

Read More
Update on the Investigator's Brochure

There are many regulatory documents but perhaps none are more critical

Read More
Clinical pharmacologists prepare for change

The latest issue of Journal Frontiers in Pharmacology has just published

Read More
Which Conference Monster Are You and How Do You Escape It?

Are you a werewolf, ghost, vampire or zombie at conferences? Explore the psychology of conference behaviour — and how to avoid becoming a...

Read More
Aiming at Supererogation

From Tuskegee to the Belmont Report, how did modern research ethics come to be? A reflection on 40 years of principles that still govern...

Read More
A EUFEMED achievement

I'm sure that everyone works hard and tries to do their best.

Read More
Revised FIH EMA Guideline: Opinion reported

The EUropean Federation for Exploratory MEdicines Development (EUFEMED

Read More
UK – Doing OK

One notable characteristic of Brexit has been a race for the bottom by journalists

Read More
Regulating medical devices in the event of a no deal scenario

Metathesiophobia: from Preclinical to Clinical Development

Read More
The Investigator’s Brochure: Multifaceted and Multidisciplinary

Metathesiophobia: from Preclinical to Clinical Development

Read More
Expanded ‘No-Deal’ Brexit preparations for pharmaceuticals and medical devices

However you may feel about the way political leaders have turned Brexit

Read More
Association for Human Pharmacology in the Pharmaceutical Industry

The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)

Read More
Women in Clinical Trials

Explore how women’s exclusion from clinical trials shaped medicine and why sex-specific data is essential for precision healthcare today.

Read More

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility